Prelude Therapeutics' Grant

Prelude Therapeutics raised a round of funding on August 15, 2017. Investors include Delaware Economic Development Office.

Prelude Therapeutics is a privately held biotechnology company focused on discovering and developing new medicines targeting chromatin function to treat cancer and rare diseases.…

Articles about Prelude Therapeutics' Grant: